Related Experiment Video
Updated: Aug 24, 2026

Deficient Pms2, ERCC1, Ku86, CcOI in Field Defects During Progression to Colon Cancer
Published on: July 28, 2010
A DNA polymerase beta mutant from colon cancer cells induces mutations
Tieming Lang1, Mausumi Maitra, Daniela Starcevic
1Department of Therapeutic Radiology, Yale University School of Medicine, New Haven, CT 06520, USA.
Abstract:
Previous investigations have shown that approximately 35% of the 90 tumors analyzed to date contain mutations within the DNA polymerasebeta (pol beta) gene. The existence of pol beta mutations in a substantial fraction of human tumors studied suggests a link between DNA pol beta and cancer. A DNA pol beta variant, in which Lys-289 has been altered to Met, was identified previously in a colorectal carcinoma. The K289M protein was expressed in mouse L cells containing the lambda cII mutational target. The lambda DNA was packaged and used to infect bacterial cells to obtain the spontaneous mutation frequency. We found that expression of K289M in the mouse cells resulted in a 2.5-fold increase in the mutation frequency. What was most interesting was that expression of K289M in these cells resulted in a 16-fold increase in the frequency of C to G or G to C base substitutions at a specific site within the cII target. By using this cII target sequence, kinetic analysis of the purified K289M protein revealed that it was able to misincorporate dCTP opposite template C and dGTP opposite template G with significantly higher efficiency than the wild-type pol beta protein. We provide evidence that misincorporation of nucleotides by K289M results from altered positioning of the DNA within the active site of the enzyme. Our data are consistent with the interpretation that misincorporation of nucleotides resulting from altered DNA positioning by the K289M protein has the potential to result in tumorigenesis or neoplastic progression.
Insights
Mutations in DNA polymerase beta (pol beta) are linked to cancer. A specific pol beta variant, K289M, increases mutation frequency and may contribute to tumor development.
Area of Science:
- Molecular Biology
- Genetics
- Cancer Research
Background:
- Approximately 35% of analyzed tumors harbor mutations in the DNA polymerase beta (pol beta) gene.
- The presence of pol beta mutations in a significant fraction of human tumors suggests a link to cancer development.
Purpose of the Study:
- To investigate the mutagenic potential of a specific DNA pol beta variant (K289M) identified in colorectal carcinoma.
- To elucidate the mechanism by which the K289M variant contributes to increased mutation frequency.
Main Methods:
- Expression of the K289M pol beta variant in mouse L cells with a lambda cII mutational target.
- Analysis of spontaneous mutation frequency and base substitution patterns.
- Kinetic analysis of purified K289M protein to assess nucleotide misincorporation efficiency.
Main Results:
- Expression of K289M resulted in a 2.5-fold increase in overall mutation frequency.
- A significant 16-fold increase in C to G or G to C base substitutions was observed at a specific site.
- K289M exhibited significantly higher efficiency in misincorporating dCTP opposite template C and dGTP opposite template G compared to wild-type pol beta.
Conclusions:
- The K289M pol beta variant demonstrates enhanced nucleotide misincorporation activity.
- Altered DNA positioning within the enzyme's active site is proposed as the mechanism for misincorporation.
- These findings suggest that K289M-induced mutations have the potential to drive tumorigenesis or neoplastic progression.
Related Concept Videos
Spontaneous and Induced Mutations
Proofreading
Errors During Replication are Corrected by the DNA Polymerase Enzyme
Proofreading
Cancers Originate from Somatic Mutations in a Single Cell
Genome Copying Errors
Mismatch Repair
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...

